Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Short Versus Long Submucosal Tunneling in Per-oral Endoscopic Myotomy (POEM) for Type II Achalasia.

29 de junho de 2026 atualizado por: Omar Mohamed Magdy Eid, Assiut University

Short Versus Long Submucosal Tunneling in Per-oral Endoscopic Myotomy (POEM) for Type II Achalasia: A Randomized Controlled Trial

this study is prospective , randomized and interventional ,will be performed on 50 patients to compare the clinical utility , safety profile and postoperative recovery metrics between short and long per-oral endoscopic myotomy , patients will be divided randomly into two equal groups one will do short myotomy and the other group will do long myotomy , each group will contain 25 patients methodology &patient selection : patients follow the inclusion criterias including :

  • Patients of all ages were eligible for inclusion in the study with no upper or lower age limits applied .
  • Both sexes are included .
  • Type II achalasia patients who are diagnosed by High Resolution. Manometry based on Chicago Classification (v4.0) characterized by (failed esophageal peristalsis , pan-esophageal pressurization in ≥20% of swallows and Integrated Relaxation Pressure (IRP) >15 mmHg ).
  • Eckardt score >3 ( moderate to severe symptoms). this study aims to compare the outcomes of short versus long esophageal myotomy in cases with type II achalasia using Eckardt score and barium study at 3 month follow up. also to evaluate difference in length of the opearation , intra-operative and post-operative adverse events between short and long submucosal tunneling.

every patient will do upper endoscopy and manometry preoperative , also ekcardt score will be caculated , follow up after 3 months by barium swallow and eckardt score

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Descrição detalhada

Aim of the study :

Primary outcome :

to compare the outcomes of short versus long esophageal myotomy in cases with type II achalasia using Eckardt score and barium study at 3 month follow up.

to evaluate difference in length of the opearation , intra-operative and post-operative adverse events between short and long submucosal tunneling.

Secondary outcome :

We aim to compare the difference in duration of hospital stay between short and long esophageal myotomy .

We aim to compare the incidence of post-operative Gastroesophageal Reflux Disease (GERD) using Los Angeles (LA) classification via upper endoscopy at 3 months.

Patients and Methods Study Design: prospective , randomized . Patients:this study will include all patients diagnosed as type II achalasia via High Resolution Manometry , this study will be conducted in internal medicine department at Assiut University Hospitals between june 2026 to june 2028.

Inclusion criteria:

Patients of all ages were eligible for inclusion in the study with no upper or lower age limits applied .

Both sexes are included . Type II achalasia patients who are diagnosed by High Resolution. Manometry based on Chicago Classification (v4.0) characterized by (failed esophageal peristalsis , pan-esophageal pressurization in ≥20% of swallows and Integrated Relaxation Pressure (IRP) >15 mmHg ).

Eckardt score >3 ( moderate to severe symptoms).

Exclusion criteria :

Type I ,type III achalasia & Non-achalasia spastic motility disorders. Sigmoid type esophagus (diameter> 6 cm ). Esophageal diverticulae . Presence of large Hiatus Hernia ( >5cm). Severe erosive esophagitis (La Grade C or D) or Barrett's Esophagus. History of previous Heller's myotomy. Pseudoachalasia due to underlying malignancy. Severe coagulopathy ( INR>1.5 or platelets <50000 ).

Methodology :

All patients will be subjected to the following:

Preoperative evaluation:

•Eckardt score: All patients were assessed using the Eckardt score for symptom severity, which is based on dysphagia, chest pain, regurgitation, and weight loss symptoms. Each component of the Eckardt score is assigned a value from 0 to 3 according to the patient's self-reported response, with the total score ranging from 0 to 12. Higher scores indicate more severe symptoms.(7)

Upper Gastrointestinal Endoscopy :

Patients shoud be fasting for 8 hours and the procedure was performed under general anesthesia It is used to comment on esophageal peristalsis, dilatation, LES, any residual food were noted.

High Resolution Manometry :

All the patients assessed by High Resolution Manometry , for evaluation of esophageal peristalsis, LES pressure, integral resting pressure (IRP), and ineffective contractions and to differentiate between achalasia types.

Certain instructions were followed :

Patients were instructed to stop any medication that may influence esophageal motility (calcium channel blocker, nitrates, loperamide, prokinetics, beta-blocker, and opioids).

Patients were instructed for complete fasting for 12h before procedure. An HRM catheter was introduced transnasally in the supine position and positioned by observing the appearance of a high-pressure zone at the distal end of the LES.

Patients were instructed not to swallow for 30 s to detect the resting pressure among esophagus.

Patients were then instructed to take 5ml of water in each swallow of 10 successive swallows separated by 30 s interval for assessment of esophageal body peristalsis.(8)

Barium swallow :

it is performed to all patients to detect bird peak appearance , dilated esophagus ,retained food or sigmoid esophagus.

Hematological investigation :

Venous blood samples will be drawn into 2 mL EDTA tubes. Complete blood count will be analyzed within 2 hours after venipuncture using an automated hematology analyzer. The parameters analyzed will be Hemoglobin, platelet count and White Blood Cells.

Differential leucocyte counts will be done on peripheral smear. Neutrophil -to-Lymphocyte Ratio (NLR) will be calculated.

Other hematological parameters will be done like (CRP and ESR ). Coagulation profile (PC , PT ,INR )

Per-oral Endoscopic Myotomy Technique :

POEM was performed by experienced endoscopist . All procedures were performed under general anesthesia with the patients in the supine position. POEM was performed by anterior (1-2 O'clock) route in all cases. The steps of POEM procedure were as follows:

submucosal injection using a solution of saline mixed with indigocarmine dye . vertical mucosal incision measuring 2 cm to 2.5 cm in length. submucosal tunneling extending up to 2 cm to 4 cm below the Gastroesophageal junction ( GEJ) .

myotomy extending from 1 cm to 2 cm below the distal edge of mucosal incision until the lower end of the tunnel and closure of the mucosal incision with several endoclips ,Triangular tip knife (KD-645L; Olympus, Tokyo, Japan) with integrated water jet function was utilized for the entire procedure including mucosal incision, submucosal tunneling, and myotomy (Spray Coag 50 W).

The important technical differences in the short and long myotomy groups were as follows. The length of esophageal myotomies (≤ 3 cm vs ≥ 6 cm) were different in both groups. Whereas, the length of gastric myotomies were similar (2-4 cm) in either group. In the short myotomy group, the mucosal incision was performed at about 5-6 cm above the gastroesophageal junction (GEJ). The length of esophageal myotomy was 2 cm to 3 cm and the entire extent of the myotomy was full thickness in the short myotomy group. Whereas in the long myotomy group, the mucosal incision was performed at least 8 cm above the GEJ and the length of esophageal myotomy was ≥ 6 cm. Selective circular myotomy was performed in the upper part of the tunnel and full thickness myotomy was performed from 2-3 cm above the GEJ until the lower end of the tunnel. The length of gastric myotomy was kept similar in both groups ie, 2-4 cm. The extent of esophageal and gastric myotomies were assessed using scope withdrawal, and fluoroscopy . In cases with uncertainty regarding the gastric length of myotomy, double scope method was used for confirmation.(9) Adverse events: events requiring an additional procedure such as needle drainage for capno-peritoneum, temporary cessation of procedure due to accumulation of retroperitoneal CO2 , mucosal injuries requiring closure with endoclips, and intra-procedural or post-procedural events leading to prolongation of hospital stay were considered as adverse events.(10)

Postoperative evaluation :

All patients will be followed up by hematological investigations like CBC , CRP and ESR to all patients 24 hrs postoperative.

All patients will be followed up by barium swallow and Eckardt score at 3 month duration .

All patients will be underwent upper endoscopy at 3 months duration .

Tipo de estudo

Intervencional

Inscrição (Estimado)

50

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

      • Asyut, Egito, 71511
        • Assiut university hosoital
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Patients of all ages were eligible for inclusion in the study with no upper or lower age limits applied .
  • Both sexes are included .
  • Type II achalasia patients who are diagnosed by High Resolution. Manometry based on Chicago Classification (v4.0) characterized by (failed esophageal peristalsis , pan-esophageal pressurization in ≥20% of swallows and Integrated Relaxation Pressure (IRP) >15 mmHg ).
  • Eckardt score >3 ( moderate to severe symptoms

Exclusion Criteria:

  • Type I ,type III achalasia & Non-achalasia spastic motility disorders.
  • Sigmoid type esophagus (diameter> 6 cm ).
  • Esophageal diverticulae .
  • Presence of large Hiatus Hernia ( >5cm).
  • Severe erosive esophagitis (La Grade C or D) or Barrett's Esophagus.
  • History of previous Heller's myotomy.
  • Pseudoachalasia due to underlying malignancy.
  • Severe coagulopathy ( INR>1.5 or platelets <50000 ).

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: short POEM group
Per-oral endoscopic myotomy (POEM) will be performed under general anesthesia. The procedure involves four main steps: (1) mucosal incision to gain entry to the submucosal space; (2) creation of a short submucosal tunnel extending down to the esophagogastric junction; (3) short endoscopic myotomy of the circular muscle layer; and (4) closure of the mucosal entry site using endoscopic clips
Per-oral endoscopic myotomy (POEM) will be performed under general anesthesia. The procedure involves four main steps: (1) mucosal incision to gain entry to the submucosal space; (2) creation of a submucosal tunnel extending down to the esophagogastric junction; (3) endoscopic myotomy of the circular muscle layer, where the longitudinal length of the myotomy (short vs. long) is determined strictly by the patient's randomized group assignment; and (4) closure of the mucosal entry site using endoscopic clips.
Experimental: long POEM group
Per-oral endoscopic myotomy (POEM) will be performed under general anesthesia. The procedure involves four main steps: (1) mucosal incision to gain entry to the submucosal space; (2) creation of a long submucosal tunnel extending down to the esophagogastric junction; (3) long endoscopic myotomy of the circular muscle layer; and (4) closure of the mucosal entry site using endoscopic clips.
Per-oral endoscopic myotomy (POEM) will be performed under general anesthesia. The procedure involves four main steps: (1) mucosal incision to gain entry to the submucosal space; (2) creation of a submucosal tunnel extending down to the esophagogastric junction; (3) endoscopic myotomy of the circular muscle layer, where the longitudinal length of the myotomy (short vs. long) is determined strictly by the patient's randomized group assignment; and (4) closure of the mucosal entry site using endoscopic clips.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
change from baseline eckardt score at 3 months
Prazo: 3 months postoperatively
the eckardt score is a clinical grading for achalasia evaluating four symtoms dysphagia , regurgitation , retrosternal pain and weight loss ( each scored 0to3 , total score ranges from 0 to 12 where higher scores indicate severe symtoms
3 months postoperatively
postoperative barium column height at 3 months
Prazo: 3 month postoperatively
evaluation of esophageal emptying by measuring the height of timed barium in centimeters at 1,2and 5 minutes during the barium swallow
3 month postoperatively
total operative operation
Prazo: during the operation (from incision to closure )
total time taken to complete the procedure , measured in minutes from initial mucosal incision to final closure
during the operation (from incision to closure )
incidence of intraoperative adverse events
Prazo: during the operation
number of participants who experience intraoperative complications such as mucosal perforation or significant hemorrhage during submucosal tunneling
during the operation
post-operative complications
Prazo: from the completion of operation upto the hospital discharge ( within 48 hr)
number of participants experiencing post-operative complications ( e.g delayed bleeding , infection,or leakage )
from the completion of operation upto the hospital discharge ( within 48 hr)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
length of hospital stay
Prazo: from day of the procedure until the day of official hospital discharge
total number of days spent in the hospital , calculatef from day of the procedure until the day of official hospital discharge
from day of the procedure until the day of official hospital discharge
incidence of post-operative reflux esophagitis
Prazo: 3 months postoperatively
the percentage of participants diagnosed with gastresophageal reflux disease ( GERD)evaluated via upper gastrointestinal endoscopy and graded according to los angelos(LA) classification system (grades A to D , where higher grades indicate more severe mucosal breaks
3 months postoperatively

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Omar M Magdy, master dgree, Assiut University Hospitals

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

28 de junho de 2026

Conclusão Primária (Estimado)

16 de junho de 2028

Conclusão do estudo (Estimado)

16 de dezembro de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

24 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

29 de junho de 2026

Primeira postagem (Real)

7 de julho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

7 de julho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

29 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever